ODC1 and cancer: It is likely that the variation in the promoter region makes ODC more susceptible for overexpression in some cancers and thus inhibition of polyamine synthesis by DFMO and/or NSAIDs is particularly effective in cancer prevention in patients exhibiting this polymorphism.